CD19 and endothelial dysfunction: In addition, neither CD4- and CD19-specific CD40 deficiency (accounting for T cells and B cells) nor GPb1a-specific CD40L deficiency (accounting for platelets) showed improvement in blood pressure or endothelial dysfunction (Fig. 6).